𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A NEW STRATEGY FOR DISCONTINUATION OF DUAL ANTIPLATELET THERAPY: REAL SAFETY AND EFFICACY OF 3 MONTHS DUAL ANTIPLATELET THERAPY FOLLOWING ENDEAVOR ZOTAROLIMUS-ELUTING STENT IMPLANTATION

✍ Scribed by Myeong-Ki Hong; Byeong-Keuk Kim; Dong-Ho Shin; Young-Guk Ko; Donghoon Choi; Jung-Han Yoon; Hyuck-Moon Kwon; Yangsoo Jang

Book ID
118581820
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
108 KB
Volume
59
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rationale and design of a randomized, do
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study
✍ Robert A. Byrne; Stefanie Schulz; Julinda Mehilli; Raisuke Iijima; Steffen Massb πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 183 KB
Rationale and design of the dual antipla
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions
✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 307 KB